Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-02-19 Semiconductors
  • [Disclosure] SK Square (402340) – Decision on Record Date for Cash/In-Kind Dividend / 2025-07-23 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-03-27 Disclosures
  • [Disclosure] Hanwha Aerospace(012450) – Decision on Acquisition of Other Corporation’s Stocks and Investment Securities / 2026-05-04 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase / 2025-01-23 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Server DRAM · eSSD · Earnings Upgrades / 2026-04-09 RESEARCH
  • [Disclosure] Samsung Electronics (005930) – Other Major Management Matters (Voluntary Disclosure) / 2024-10-31 Semiconductors

[Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase / 2024-06-14

Posted on June 14, 2024August 9, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART / KOSCOM

💡 3-Second Summary

This filing discloses that Hanwha Ocean’s U.S. subsidiary, Hanwha Ocean USA Holdings Corp., decided to execute a shareholder-allocated rights offering of 2,650 common shares to raise approximately KRW 363.3B (USD 265M) for acquiring securities of another corporation.

📊 [Key Disclosure Highlights & Summary]

  • Filing Type: Decision on Paid-in Capital Increase (Major Matters of Subsidiary)
  • Subsidiary Name: Hanwha Ocean USA Holdings Corp. (U.S. Subsidiary / Representative: Seok-Won Lee / Core Business: Maritime Service)
  • Decision Date: June 13, 2024 (Board approval date of the subsidiary)

[Detailed Terms of Capital Increase]

  • Capital Increase Method: Shareholder-allocated rights offering (Wholly owned by Hanwha Ocean)
  • Number of New Shares: 2,650 common shares (Total shares before increase: 1,352 shares)
  • New Shares Allocated per Share: 1.9600592 shares
  • Purpose of Funds: Acquisition of securities of another corporation KRW 363,300,000,000 (USD 265,000,000; applied exchange rate of USD 1 = KRW 1,371.00 as of June 14, 2024; rounded to the nearest hundred million KRW)
  • Payment Date: December 31, 2024 (Target completion date; capital will be injected in installments based on project progress)
  • Treatment of Unsubscribed Shares: Not applicable

[Other Material Notes]

  • Exemption from registration statement filing as the subsidiary is an unlisted foreign entity.
  • The KRW conversion value may fluctuate depending on exchange rates at the time of actual capital injections.
  • Subsidiary asset total (KRW 0) reflects the March 31, 2024 settlement date; a USD 17.3M contribution was completed on April 4, 2024.
  • Related Disclosures: June 14, 2024 – Decision on Acquisition of Securities of Other Corporations

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Installment Payments and Final Completion Status

This filing details a rights offering by a U.S. subsidiary to raise funds for acquiring securities of another corporation, making it essential to monitor whether capital injections are completed in installments as planned by the target payment date (December 31, 2024) in line with project progress. Verifying these developments is necessary because it serves as the benchmark to confirm the execution status of the subsidiary’s financing and acquisition plans. Detailed payment updates can be confirmed through future regular financial reports (Quarterly, Semi-Annual, or Annual Business Reports) or subsequent official public disclosures.

📢 Disclaimer & Source Notice

Source: This content was newly structured based on official data submitted to the Financial Supervisory Service’s DART system and KOSCOM.

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Decision on Acquisition of Securities of Other Corporations / 2024-06-14
Next Post: [Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase / 2024-06-14

Related Posts

  • [Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2025-02-10 Disclosures
  • [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2025-11-10 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – (Correction) Submission of Audit Report / 2026-02-19 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Termination of Trust Contract for Treasury Stock Acquisition / 2025-01-22 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Announcement / 2026-02-24 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Financial Results Release / 2025-04-14 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2024-11-04 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Consolidated Financial Results (Provisional) (Fair Disclosure) / 2026-07-14 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Modification of Phase 3 Clinical Trial Plan in Europe for CT-P55 (Cosentyx Biosimilar) (Part 1 & 2) / 2025-10-27 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Change in Chief Executive Officer (CEO) / 2024-03-27 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – (Correction) Decision on Loan of Funds / 2025-04-23 Semiconductors
  • [Disclosure] Celltrion (068270) – Approval of US FDA Marketing Authorization for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-12-18 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Investor Relations (IR) Hosting (Notice Disclosure) / 2026-07-15 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2024-10-17 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme